Search

Your search keyword '"Bigner, Darell D"' showing total 1,547 results

Search Constraints

Start Over You searched for: Author "Bigner, Darell D" Remove constraint Author: "Bigner, Darell D"
1,547 results on '"Bigner, Darell D"'

Search Results

2. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity.

3. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis

5. Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy

6. EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis

7. The Somatic Genomic Landscape of Glioblastoma

8. Subgroup-specific structural variation across 1,000 medulloblastoma genomes.

10. Repurposing Clemastine to Target Glioblastoma Cell Stemness

17. Abstract 4924: Alternative lengthening of telomeres is associated with hypersensitivity to topoisomerase 1 inhibition in glioblastoma xenograft models

18. Supplementary Table 2 from Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression

19. Supplementary Figure 3 from CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains

20. Supplementary Figure 2 from CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains

21. Supplementary Table 3 from Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression

22. Supplementary Figure 1 from CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains

23. Supplementary Figures 1 through 5 from Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression

24. Data from Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression

25. Data from CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains

26. Supplementary Materials and Methods from Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression

27. Supplementary Table 1 from Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression

30. Supplementary Table S2 from Cic Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation

31. Data from Cic Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation

32. Supplementary Figure 7 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

33. Data from Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma

34. Figure S1_S2 from Cic Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation

35. Table S2 from A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma

36. Supplementary Table S1 from Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas

38. Table S2 from Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma

39. Data from Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1R132H-Induced Metabolic Liabilities

40. Figure S3 to S5 from Cic Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation

41. Supplemental Dataset A - IDH1-R132H effect on the metabolome. from Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1R132H-Induced Metabolic Liabilities

42. Supplementary Figures 1-9 from Construction of an Immunotoxin, D2C7-(scdsFv)-PE38KDEL, Targeting EGFRwt and EGFRvIII for Brain Tumor Therapy

43. Supplementary Figure 5 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

44. Supplementary Figure 4 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

45. Supplementary Figure 1 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

46. Figure S1 from A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma

47. Supplementary Data from Development of a Real-time RT-PCR Assay for Detecting EGFRvIII in Glioblastoma Samples

48. Figure S1- S10 from Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1R132H-Induced Metabolic Liabilities

49. Supplementary Figure 2 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

50. Figure S2 from Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma

Catalog

Books, media, physical & digital resources